Boundless Bio BOLD Income Statement (2023-2026)

NASDAQ BOLD
$2.90 +0.04 (+1.40%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 1.19M1.21M1.23M1.25M1.26M22.25M22.25M16.98M22.30M22.39M22.39M22.41M22.41M22.75M
Operating items
Research & Development (Quarter) 9.50M11.07M11.64M10.41M13.13M14.73M14.09M13.31M12.14M12.22M10.67M9.82M9.73M13.97M
Wages, Salaries and Other (Quarter) 0.79M1.00M0.75M2.27M
Selling, General & Administrative (Quarter) 2.58M2.88M3.31M3.38M3.75M4.66M4.63M4.96M5.20M4.84M4.47M4.18M4.74M10.41M
Restructuring Costs (Quarter) 0.37M0.59M0.69M0.68M0.73M0.62M0.54M0.53M0.49M
Other Operating Expenses (Quarter) -0.37M-0.59M-0.69M-0.68M-0.73M-0.62M-0.54M-0.53M-0.49M
Operating Expenses (Quarter) 12.09M13.96M14.95M13.80M16.88M19.39M18.71M18.28M17.34M17.06M15.15M14.00M14.47M24.38M
Operating Income (Quarter) -12.09M-13.96M-14.95M-13.80M-16.88M-19.39M-18.71M-18.28M-17.34M-17.06M-15.15M-14.00M-14.47M-24.38M
EBIT (Quarter) -12.09M-13.96M-14.95M-13.80M-16.88M-19.39M-18.71M-18.28M-17.34M-17.06M-15.15M-14.00M-14.47M-24.38M
Non-operating items
Interest & Investment Income (Quarter) 0.40M1.55M1.75M1.62M-0.06M-0.04M2.17M1.92M1.58M-0.04M1.27M1.12M0.92M0.69M
Other Non Operating Income (Quarter) -0.03M0.01M0.03M0.03M0.03M0.03M0.03M-0.09M-0.00M0.00M
Non Operating Income (Quarter) 0.37M1.56M1.78M1.65M1.45M2.42M2.21M1.83M1.58M1.39M1.27M1.12M0.92M0.69M
Net income details
EBT (Quarter) -12.39M-13.11M-13.90M-12.88M-50.32M-20.23M-16.64M-16.86M-15.86M-24.57M-85.43M-14.69M-81.63M-26.43M
Profit After Tax (Quarter) -11.72M-12.42M-13.17M-12.14M-15.43M-16.98M-16.51M-16.37M-15.76M-15.71M-13.88M-12.81M-13.60M-23.70M
Income from Continuing Operations (Quarter) -12.39M-13.11M-13.90M-12.88M-50.32M-20.23M-16.64M-16.86M-15.86M-24.57M-85.43M-14.69M-81.63M-26.43M
Consolidated Net Income (Quarter) -12.39M-13.11M-13.90M-12.88M-50.32M-20.23M-16.64M-16.86M-15.86M-24.57M-85.43M-14.69M-81.63M-26.43M
Income towards Parent Company (Quarter) -12.39M-13.11M-13.90M-12.88M-50.32M-20.23M-16.64M-16.86M-15.86M-24.57M-85.43M-14.69M-81.63M-26.43M
Net Income towards Common Stockholders (Quarter) -12.39M-13.11M-13.90M-12.88M-50.32M-20.23M-16.64M-16.86M-15.86M-24.57M-85.43M-14.69M-81.63M-26.43M
Additional items
EPS (Basic) (Quarter) -10.48-10.87-11.30-10.59-40.00-0.92-0.75-0.99-0.71-1.10-3.82-0.66-3.64-1.18
EPS (Diluted) (Quarter) -10.48-10.87-11.30-10.59-40.00-0.92-0.75-0.99-0.71-1.10-3.82-0.66-3.64-1.18
Shares Outstanding (Quarter) 1.18M1.21M1.23M1.22M1.26M22.02M22.25M16.98M22.30M22.36M22.39M22.36M22.41M22.45M
Shares Outstanding (Diluted) (Quarter) 1.18M1.21M1.23M1.22M1.26M22.02M22.25M16.98M22.30M22.36M22.39M22.36M22.41M22.45M
EBITDA (Quarter) -12.09M-13.96M-14.95M-13.80M-16.88M-19.39M-18.71M-18.28M-17.34M-17.06M-15.15M-14.00M-14.47M-24.38M
Interest Expenses (Quarter) 0.70M0.70M0.70M0.70M33.38M0.80M0.10M0.50M0.10M7.47M71.55M1.80M68.08M2.74M